Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Global

iShares Global Healthcare ETF

+ Add to Watchlist

IXJ:AU

136.9200 AUD 0.2300 0.17%

As of 21:46:09 ET on 03/03/2015.

Snapshot for iShares Global Healthcare ETF (IXJ)

Open: 137.1500 High - Low: 137.4300 - 136.4100 Primary Exchange: ASE
Volume: 9,030 52-Week Range: 92.3400 - 138.8600 Beta vs SGHNW: 0.8645

ETF Chart for IXJ

No chart data available.
  • IXJ:AU 136.9200
  • 1D
  • 1M
  • 1Y
137.1500
Interactive IXJ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IXJ

iShares Global Healthcare ETF is an exchange-traded fund incorporated in the USA. The ETF tracks the S&P Global Healthcare Index. The ETF holds global large- cap health care stocks. Its investments are focused in pharmaceutical, biotech, and medical device companies, with its largest allocation to the United States. A market capitalization methodology is used for weighting.

Inception Date: 2009-03-12 Telephone: 1-415-670-2000
Managers: GREG SAVAGE / DIANE HSIUNG
Web Site: www.ishares.com

Fundamentals for IXJ

NAV -
Assets (M) (on 2015-03-03) 1,611.3050
Shares out (M) 9.15
Market Cap (M) 1,249.25
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for IXJ

Dividend Type Income
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-22) 0.3858
Dividend Yield (ttm) 1.11%

Performance for IXJ

1-Month +2.51% 1-Year +35.06%
3-Month +11.52% 3-Year +38.62%
Year To Date +11.58% 5-Year +21.18%
Expense Ratio 0.48

Top Fund Holdings for IXJ

Filing Date: 03/02/2015
Name Position Value % of Total
Johnson & Johnson 1,056,300 109,031,286 6.804%
Novartis AG 1,020,900 104,543,574 6.524%
Pfizer Inc 2,377,800 82,676,106 5.159%
Roche Holding AG 265,200 72,327,273 4.513%
Merck & Co Inc 1,075,800 63,020,364 3.932%
Gilead Sciences Inc 569,400 59,120,802 3.689%
Bayer AG 312,000 46,072,618 2.875%
Amgen Inc 287,100 45,829,773 2.860%
GlaxoSmithKline PLC 1,839,900 43,925,929 2.741%
Sanofi 453,900 43,905,349 2.740%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil